Cargando…
Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613680/ https://www.ncbi.nlm.nih.gov/pubmed/31283793 http://dx.doi.org/10.1371/journal.pone.0219614 |
| _version_ | 1783433073571921920 |
|---|---|
| author | Jablonska, Paola Anna Diez-Valle, Ricardo Gállego Pérez-Larraya, Jaime Moreno-Jiménez, Marta Idoate, Miguel Ángel Arbea, Leire Tejada, Sonia de Eulate, Maria Reyes Garcia Ramos, Luis Arbizu, Javier Domínguez, Pablo Aristu, José Javier |
| author_facet | Jablonska, Paola Anna Diez-Valle, Ricardo Gállego Pérez-Larraya, Jaime Moreno-Jiménez, Marta Idoate, Miguel Ángel Arbea, Leire Tejada, Sonia de Eulate, Maria Reyes Garcia Ramos, Luis Arbizu, Javier Domínguez, Pablo Aristu, José Javier |
| author_sort | Jablonska, Paola Anna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6613680 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66136802019-07-23 Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience Jablonska, Paola Anna Diez-Valle, Ricardo Gállego Pérez-Larraya, Jaime Moreno-Jiménez, Marta Idoate, Miguel Ángel Arbea, Leire Tejada, Sonia de Eulate, Maria Reyes Garcia Ramos, Luis Arbizu, Javier Domínguez, Pablo Aristu, José Javier PLoS One Correction Public Library of Science 2019-07-08 /pmc/articles/PMC6613680/ /pubmed/31283793 http://dx.doi.org/10.1371/journal.pone.0219614 Text en © 2019 Jablonska et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Jablonska, Paola Anna Diez-Valle, Ricardo Gállego Pérez-Larraya, Jaime Moreno-Jiménez, Marta Idoate, Miguel Ángel Arbea, Leire Tejada, Sonia de Eulate, Maria Reyes Garcia Ramos, Luis Arbizu, Javier Domínguez, Pablo Aristu, José Javier Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience |
| title | Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience |
| title_full | Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience |
| title_fullStr | Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience |
| title_full_unstemmed | Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience |
| title_short | Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience |
| title_sort | correction: hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. a prospective, single-institution experience |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613680/ https://www.ncbi.nlm.nih.gov/pubmed/31283793 http://dx.doi.org/10.1371/journal.pone.0219614 |
| work_keys_str_mv | AT jablonskapaolaanna correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT diezvallericardo correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT gallegoperezlarrayajaime correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT morenojimenezmarta correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT idoatemiguelangel correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT arbealeire correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT tejadasonia correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT deeulatemariareyesgarcia correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT ramosluis correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT arbizujavier correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT dominguezpablo correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience AT aristujosejavier correctionhypofractionatedradiationtherapyandtemozolomideinpatientswithglioblastomaandpoorprognosticfactorsaprospectivesingleinstitutionexperience |